LIFR anticorps (AA 522-691)
-
- Antigène Voir toutes LIFR Anticorps
- LIFR (Leukemia Inhibitory Factor Receptor alpha (LIFR))
-
Épitope
- AA 522-691
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp LIFR est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunofluorescence (fixed cells) (IF/ICC)
- Purification
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
- Immunogène
- LIFR (Trp522-Phe691)
- Top Product
- Discover our top product LIFR Anticorps primaire
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 500 μg/mL
- Buffer
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Store at 4 °C for frequent use. Aliquot and store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
-
- Antigène
- LIFR (Leukemia Inhibitory Factor Receptor alpha (LIFR))
- Autre désignation
- Leukemia Inhibitory Factor Receptor (LIFR Produits)
- Synonymes
- anticorps A230075M04Rik, anticorps AW061234, anticorps LIF, anticorps CD118, anticorps LIF-R, anticorps SJS2, anticorps STWS, anticorps SWS, anticorps leukemia inhibitory factor receptor, anticorps LIF receptor alpha, anticorps leukemia inhibitory factor receptor alpha, anticorps Lifr, anticorps LOC397451, anticorps LIFR
- UniProt
- P42702
- Pathways
- Signalistation JAK/STAT, Growth Factor Binding
-